StockNews.com assumed coverage on shares of SenesTech (NASDAQ:SNES – Free Report) in a report published on Wednesday. The brokerage issued a sell rating on the stock.
SenesTech Price Performance
Shares of SNES stock opened at $0.86 on Wednesday. The firm’s 50-day simple moving average is $0.77 and its 200-day simple moving average is $1.35. The company has a current ratio of 8.49, a quick ratio of 7.48 and a debt-to-equity ratio of 0.02. SenesTech has a 1-year low of $0.52 and a 1-year high of $19.20.
Institutional Trading of SenesTech
An institutional investor recently bought a new position in SenesTech stock. Armistice Capital LLC purchased a new stake in shares of SenesTech, Inc. (NASDAQ:SNES – Free Report) in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 70,425 shares of the company’s stock, valued at approximately $30,000. Armistice Capital LLC owned 1.94% of SenesTech at the end of the most recent quarter. 5.19% of the stock is currently owned by institutional investors and hedge funds.
About SenesTech
SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
Featured Stories
- Five stocks we like better than SenesTech
- What is Forex and How Does it Work?
- MarketBeat Week in Review – 4/29 – 5/3
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Apple’s Earnings Show Investors Its Strength and Its Weakness
- What is an Earnings Surprise?
- Bargain Alert: 3 Large Caps With Extremely Oversold RSIs
Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.
